NERV
Minerva Neurosciences Inc
3.30$
-4.7%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | -98.8% | +0.0% | +8,605,825.0% | +87,187.7% | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | -100.0% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +2.8% | -66.1% | – | – | – | – | – | +21.3% | +0.0% | 0.0% | +0.0% | 0.0% | +0.0% | -27.5% | +275.7% | +0.0% | -93.6% | +0.1% | -0.1% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | -98.8% | -107,082,600.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | -106.4% | – | – | – | – | – | |
| – | +11.1% | +17.2% | -6.2% | +25.4% | -27.0% | +29.2% | +7.3% | -7.6% | +7.6% | +28.8% | -28.3% | +16.3% | +194.9% | -71.7% | -28.6% | -19.6% | -23.4% | -8.2% | +69.4% | -18.3% | +315.4% | -73.5% | -16.7% | -42.7% | +34.7% | -16.8% | -28.9% | +82.4% | +37.1% | -11.7% | -7.4% | -51.1% | +5.0% | -31.3% | -4.7% | -28.7% | +134.9% | +241,661.4% | -99.9% | – | |
| – | +15.1% | +4.8% | -9.4% | -5.8% | +22.1% | +43.5% | -9.8% | +4.7% | +13.9% | +1.9% | -2.6% | +0.5% | -16.6% | +9.0% | +40.9% | -41.5% | +8.6% | +13.4% | -19.0% | -12.7% | -12.4% | +15.1% | -6.5% | +0.2% | -33.8% | +43.4% | -2.3% | +0.1% | -7.0% | +2.6% | -3.9% | +2.6% | +2.4% | +0.0% | -18.3% | -7.6% | +46.3% | +406,477.6% | -100.0% | – | |
| – | +12.2% | +13.5% | -7.0% | +17.0% | -16.4% | +33.7% | +1.5% | -4.0% | +9.7% | +19.7% | -20.9% | +10.7% | +126.6% | -62.1% | -4.9% | -30.7% | -9.8% | +2.8% | +19.4% | -16.1% | +184.4% | -62.6% | -12.8% | -25.2% | -2.6% | +5.5% | -15.5% | +34.5% | +18.0% | -6.8% | -6.1% | -30.4% | +3.6% | -13.7% | -13.5% | -15.7% | +75.1% | +234.7% | -36.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -127.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -10.2% | -13.3% | -15.6% | -18.9% | -24.0% | -32.5% | -49.4% | -88.8% | +2,751,479.1% | -100.0% | – | – | – | – | – | – | – | – | +24.3% | +4.7% | +2.7% | +2.7% | +2.7% | +2.7% | +2.7% | +2.7% | +2.7% | +2.7% | +5.0% | +2.8% | +2.7% | -100.0% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -127.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -119.0% | – | – | – | – | – | – | – | |
| – | -10.2% | -13.3% | -15.6% | -18.9% | -6,899.2% | – | -49.4% | -88.8% | -100.0% | – | – | – | – | – | – | – | +13.4% | +5,015.5% | +24.3% | +4.7% | -206.9% | – | – | – | -2.2% | +117.3% | -43.6% | -100.4% | – | – | – | -140,550.0% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -7,761.3% | – | – | – | – | – | – | – | – | – | -127.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -119.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -127.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -119.0% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.